Tyler Morning Telegraph

ELIAS Animal Health Receives Full Approval from USDA for the ELIAS Cancer Immunotherapy (ECI®), First-In-Class Treatment for Canine Osteosarcoma

U.S. Department of Agriculture Center for Veterinary Biologics approves ECI®, a first-in-class adoptive cell therapy for the treatment of bone cancer in dogs ECI® is now available at 100 authorized ...
KTLA

New Study Data on Chemo-Immunotherapy Approach Using the ELIAS Cancer Immunotherapy (ECI®) to Treat Bone Cancer in Dogs Demonstrates Improved Outcomes

LENEXA, Kan., June 19, 2025 /PRNewswire/ -- ELIAS Animal Health, a leading companion animal cancer therapeutics company, today announced interim results from an ongoing clinical study evaluating ELIAS ...
KVIA

Dogs and their people: Companions in cancer research

After a train carrying chemicals derailed and caught fire in East Palestine, Ohio, in 2023, residents were exposed to carcinogens such as vinyl chloride, acrolein and dioxin. Since tumors are ...
MLive

New veterinary drug that was developed in Michigan shows promise in treating bone cancer in dogs

Cancer is always a disheartening, scary diagnosis anytime, but when it comes to your pet, you feel especially helpless. The disease is common in many breeds, pure bred and mixed alike. But imagine ...